A Study to Assess the Effect of Capivasertib on Midazolam in Patients With Advanced Solid Tumours
Clinical trial NCT04958226 · COMPLETED
Trial details
- NCT number
- NCT04958226
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-15
- Primary completion
- 2023-02-06
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.